Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target. Ozbay Kurt FG, Lasser S, Arkhypov I, Utikal J, et al. J Clin Invest 2023;133:e170762.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ozbay Kurt FG, Lasser S, Arkhypov I, Utikal J, et al. Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target. J Clin Invest 2023;133:e170762.
PMID: 37395271